Access the full text.
Sign up today, get DeepDyve free for 14 days.
H. Gerber, A. Malik, Gregg Solar, D. Sherman, X. Liang, G. Meng, K. Hong, J. Marsters, N. Ferrara (2002)
VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanismNature, 417
J. Plouët, F. Moro, Stéphane Bertagnolli, N. Coldeboeuf, H. Mazarguil, S. Clamens, F. Bayard (1997)
Extracellular Cleavage of the Vascular Endothelial Growth Factor 189-Amino Acid Form by Urokinase Is Required for Its Mitogenic Effect*The Journal of Biological Chemistry, 272
D. McDonald, P. Choyke (2003)
Imaging of angiogenesis: from microscope to clinicNature Medicine, 9
Zoya Poltorak, T. Cohen, Revital Sivan, Yelena Kandelis, G. Spira, I. Vlodavsky, E. Keshet, G. Neufeld (1997)
VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular Matrix*The Journal of Biological Chemistry, 272
R. Keck, L. Berleau, Reed Harris, B. Keyt (1997)
Disulfide structure of the heparin binding domain in vascular endothelial growth factor: characterization of posttranslational modifications in VEGF.Archives of biochemistry and biophysics, 344 1
Christopher Robinson, S. Stringer (2001)
The splice variants of vascular endothelial growth factor (VEGF) and their receptors.Journal of cell science, 114 Pt 5
F. Vázquez, J. Rodríguez-Manzaneque, J. Lydon, Dean Edwards, Bert O’Malley, M. Iruela‐Arispe (1999)
Progesterone Regulates Proliferation of Endothelial Cells*The Journal of Biological Chemistry, 274
A. Pettersson, J. Nagy, L. Brown, C. Sundberg, E. Morgan, S. Jungles, R. Carter, J. Krieger, E. Manseau, V. Harvey, I. Eckelhoefer, Dian Feng, A. Dvorak, R. Mulligan, H. Dvorak (2000)
Heterogeneity of the Angiogenic Response Induced in Different Normal Adult Tissues by Vascular Permeability Factor/Vascular Endothelial Growth FactorLaboratory Investigation, 80
I. Neiman (1974)
[Inflammation and cancer].Patologicheskaia fiziologiia i eksperimental'naia terapiia, 0 4
G. Bergers, R. Brekken, G. Mcmahon, T. Vu, T. Itoh, K. Tamaki, K. Tanzawa, P. Thorpe, S. Itohara, Z. Werb, D. Hanahan (2000)
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesisNature Cell Biology, 2
B. McColl, M. Baldwin, S. Roufail, C. Freeman, R. Moritz, R. Simpson, K. Alitalo, S. Stacker, M. Achen (2003)
Plasmin Activates the Lymphangiogenic Growth Factors VEGF-C and VEGF-DThe Journal of Experimental Medicine, 198
A. Luque, D. Carpizo, M. Iruela-Arispe (2003)
ADAMTS1/METH1 Inhibits Endothelial Cell Proliferation by Direct Binding and Sequestration of VEGF165*Journal of Biological Chemistry, 278
M. Inoue, J. Hager, N. Ferrara, H. Gerber, D. Hanahan (2002)
VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis.Cancer cell, 1 2
E. Tischer, R. Mitchell, T. Hartman, Miralva Silva, D. Gospodarowicz, J. Fiddes, Jacob Abraham (1991)
The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing.The Journal of biological chemistry, 266 18
Y. Hamano, M. Zeisberg, H. Sugimoto, Julie Lively, Y. Maeshima, Changqing Yang, R. Hynes, Z. Werb, A. Sudhakar, R. Kalluri (2003)
Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin.Cancer cell, 3 6
A. Damert, L. Miquerol, M. Gertsenstein, W. Risau, A. Nagy (2002)
Insufficient VEGFA activity in yolk sac endoderm compromises haematopoietic and endothelial differentiation.Development, 129 8
G. McQuibban, J. Gong, E. Tam, C. McCulloch, I. Clark‐Lewis, C. Overall (2000)
Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3.Science, 289 5482
H. Dvorak (2002)
Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 21
N. Ferrara, H. Gerber, J. Lecouter (2003)
The biology of VEGF and its receptorsNature Medicine, 9
V. Vincenti, Caterina Cassano, M. Rocchi, M. Persico (1996)
Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3.Circulation, 93 8
K. Houck, N. Ferrara, J. Winer, G. Cachianes, Bing Li, D. Leung (1991)
The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.Molecular endocrinology, 5 12
M. Borrell-Pages, F. Rojo, J. Albanell, J. Baselga, J. Arribas (2003)
TACE is required for the activation of the EGFR by TGF‐α in tumorsThe EMBO Journal, 22
J. Rossant, M. Hirashima (2003)
Vascular development and patterning: making the right choices.Current opinion in genetics & development, 13 4
C. Ruhrberg, H. Gerhardt, M. Golding, R. Watson, S. Ioannidou, H. Fujisawa, C. Betsholtz, D. Shima (2002)
Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis.Genes & development, 16 20
D. Darland, Patricia D'Amore (2001)
Cell-cell interactions in vascular development.Current topics in developmental biology, 52
K. Kim, Bing Li, J. Winer, M. Armanini, N. Gillett, H. Phillips, N. Ferrara (1993)
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 362
Y. Hamano, M. Zeisberg, H. Sugimoto, Julie Lively, Y. Maeshima, Changqing Yang, R. Hynes, Z. Werb, A. Sudhakar, R. Kalluri (2003)
Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrinCancer Cell, 3
C. Overall, C. López-Otín (2002)
Strategies for MMP inhibition in cancer: innovations for the post-trial eraNature Reviews Cancer, 2
L. Miquerol, B. Langille, A. Nagy (2000)
Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression.Development, 127 18
H. Hutchings, N. Ortéga, J. Plouët (2003)
Extracellular matrix‐bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligationThe FASEB Journal, 17
H. Gerber, K. Hillan, A. Ryan, J. Kowalski, G. Keller, Linda Rangell, Barbara Wright, F. Radtke, M. Aguet, N. Ferrara (1999)
VEGF is required for growth and survival in neonatal mice.Development, 126 6
N. Ferrara, K. Carver-Moore, Helen Chen, M. Dowd, Lucy Lu, K. O'shea, L. Powell-Braxton, K. Hillan, M. Moore (1996)
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF geneNature, 380
E. Bergsten, M. Uutela, X. Li, K. Pietras, A. Ostman, C. Heldin, K. Alitalo, U. Eriksson (2001)
PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor.Nature cell biology, 3 5
D. Nanba, A. Mammoto, K. Hashimoto, S. Higashiyama (2003)
Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZFThe Journal of Cell Biology, 163
N. Etcoff, P. Ekman, John Magee, M. Frank (2000)
Lie detection and language comprehensionNature, 405
(2000)
Formation of endothelial cell networks
P. Carmeliet, Valérie Ferreira, G. Breier, S. Pollefeyt, L. Kieckens, M. Gertsenstein, M. Fahrig, A. Vandenhoeck, K. Harpal, Carmen Eberhardt, C. Declercq, J. Pawling, L. Moons, D. Collen, W. Risau, A. Nagy (1996)
Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 380
Jeremy Grunstein, Joseph Masbad, Reed Hickey, F. Giordano, R. Johnson (2000)
Isoforms of Vascular Endothelial Growth Factor Act in a Coordinate Fashion To Recruit and Expand Tumor VasculatureMolecular and Cellular Biology, 20
K. Houck, D. Leung, A. Rowland, Jane Wirier, N. Ferrara (1992)
Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.The Journal of biological chemistry, 267 36
A. Pozzi, P. Moberg, L. Miles, S. Wagner, P. Soloway, H. Gardner (2000)
Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization.Proceedings of the National Academy of Sciences of the United States of America, 97 5
M. Balbín, A. Fueyo, A. Tester, A. Pendás, A. Pitiot, A. Astudillo, C. Overall, S. Shapiro, C. López-Otín (2003)
Loss of collagenase-2 confers increased skin tumor susceptibility to male miceNature Genetics, 35
G. McQuibban, J. Gong, J. Wong, J. Wallace, I. Clark‐Lewis, C. Overall (2002)
Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo.Blood, 100 4
M. Borrell-Pages, F. Rojo, J. Albanell, J. Baselga, J. Arribas (2003)
TACE is required for the activation of the EGFR by TGF-alpha in tumors.The EMBO journal, 22 5
P. Carmeliet, R. Jain (2000)
Angiogenesis in cancer and other diseasesNature, 407
T. Junttila, Maria Sundvall, J. Määttä, K. Elenius (2000)
Erbb4 and its isoforms: selective regulation of growth factor responses by naturally occurring receptor variants.Trends in cardiovascular medicine, 10 7
P. Fuentes-Prior, Yoriko Iwanaga, R. Huber, R. Pagila, G. Rumennik, M. Seto, J. Morser, D. Light, W. Bode (2000)
Structural basis for the anticoagulant activity of the thrombin–thrombomodulin complexNature, 404
N. Ferrara, K. Hillan, H. Gerber, W. Novotny (2004)
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNature Reviews Drug Discovery, 3
N. Ferrara (2002)
VEGF and the quest for tumour angiogenesis factorsNature Reviews Cancer, 2
J. Park, G. Keller, N. Ferrara (1993)
The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.Molecular biology of the cell, 4 12
B. Heissig, K. Hattori, M. Friedrich, S. Rafii, Z. Werb (2003)
Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinasesCurrent Opinion in Hematology, 10
M. O’Reilly, D. Wiederschain, W. Stetler-Stevenson, J. Folkman, M. Moses (1999)
Regulation of Angiostatin Production by Matrix Metalloproteinase-2 in a Model of Concomitant Resistance*The Journal of Biological Chemistry, 274
N. Ferrara (2000)
VEGF: an update on biological and therapeutic aspects.Current opinion in biotechnology, 11 6
T. Sioussat, Harold Dvorak, T. Brock, D. Senger (1993)
Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies.Archives of biochemistry and biophysics, 301 1
J. Rodríguez-Manzaneque, T. Lane, M. Ortega, R. Hynes, J. Lawler, M. Iruela-Arispe (2001)
Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factorProceedings of the National Academy of Sciences of the United States of America, 98
Vascular endothelial growth factor (VEGF) is a critical mediator of blood vessel formation during development and in pathological conditions. In this study, we demonstrate that VEGF bioavailability is regulated extracellularly by matrix metalloproteinases (MMPs) through intramolecular processing. Specifically, we show that a subset of MMPs can cleave matrix-bound isoforms of VEGF, releasing soluble fragments. We have mapped the region of MMP processing, have generated recombinant forms that mimic MMP-cleaved and MMP-resistant VEGF, and have explored their biological impact in tumors. Although all forms induced similar VEGF receptor 2 phosphorylation levels, the angiogenic outcomes were distinct. MMP-cleaved VEGF promoted the capillary dilation of existent vessels but mediated a marginal neovascular response within the tumor. In contrast, MMP-resistant VEGF supported extensive growth of thin vessels with multiple and frequent branch points. Our findings support the view that matrix-bound VEGF and nontethered VEGF provide different signaling outcomes. These findings reveal a novel aspect in the regulation of extracellular VEGF that holds significance for vascular patterning. Footnotes Abbreviations used in this paper: CAM, chorioallantoic membrane; HEK, human embryonic kidney; MALDI-TOF MS, matrix-assisted laser desorption time-of-flight MS; MMP, matrix metalloproteinase; μLC/MS n , capillary and microcapillary nano–liquid chromatography MS; μLC/MS/MS, microcapillary reverse-phase HPLC nano-electrospray tandem MS; MS, mass spectrometry; PAE, porcine aortic endothelial; PAE-VEGFR2, PAE cells expressing VEGFR2; PECAM, platelet/endothelial cell adhesion molecule 1; TIMP, tissue inhibitor of MPs; VEGFR2, VEGF receptor 2. Submitted: 20 September 2004 Accepted: 4 March 2005
The Journal of Cell Biology – Rockefeller University Press
Published: May 23, 2005
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.